Zacks Investment Management’s Avanos Medical AVNS Stock Holding History

Zacks Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,935	Closed	-$335K	–	675
2024 Q3	$335K	Buy	+13,935	New	+$318K	﹤0.01%	539
2018 Q4	–	Sell	-47,466	Closed	-$3.25M	–	510
2018 Q3	$3.25M	Sell	47,466 -10,417	-18%	-$670K	0.07%	196
2018 Q2	$3.31M	Buy	+57,883	New	+$3.06M	0.07%	191
2016 Q4	–	Sell	-6,802	Closed	-$236K	–	640
2016 Q3	$236K	Buy	+6,802	New	+$238K	0.01%	540
2015 Q2	–	Sell	-5,478	Closed	-$270K	–	630
2015 Q1	$270K	Buy	+5,478	New	+$254K	0.01%	529

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Zacks Investment Management's AVNS Position: Q4 2024 in Review

Zacks Investment Management sold out of Avanos Medical (AVNS) in Q4 2024, closing a stake of 13,935 shares — an estimated $335K sold.

Zacks Investment Management first reported a position in AVNS in Q1 2015 and held it in 5 quarters. The position peaked at $3.31M in Q2 2018. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

Zacks Investment Management reported no remaining Avanos Medical position as of Q4 2024 after selling out during the quarter.
Zacks Investment Management sold 13,935 Avanos Medical shares in Q4 2024, an estimated $335K.
Zacks Investment Management first reported a position in Avanos Medical in Q1 2015 and held it in 5 quarters.
Zacks Investment Management's Avanos Medical position peaked at $3.31M in Q2 2018.
258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on Zacks Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.